The objective of the study is to analyze the key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. To track company developments such as acquisitions, product launches, expansions, agreements, and partnerships of the leading players, the competitive landscape of the hemostats market to analyze market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments, the market breakdown and data triangulation were used.
The four steps involved in estimating the market size are
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales managers, marketing managers, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
|
COMPANY NAME |
DESIGNATION |
|
Johnson & Johnson |
Regional Manager |
|
Baxter International |
Senior Product Manager |
|
Meril Life Sciences |
Marketing Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the hemostats market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Global Hemostats Market Size: Botton Up Approach
Global Hemostats Market Size: Top-Down Approach
Data Triangulation
After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
When a blood vessel is damaged during surgery, the resulting blood loss must be stopped immediately. The process of stopping this bleeding is called hemostasis. Hemostats provide a temporary block by forming blood clots to control bleeding. The use of hemostats must be quick, localized, and carefully regulated. Hemostats are primarily required when the bleeding is heavy or the patient is suffering from congenital diseases or trauma defects.
Stakeholders
-
Senior Management
-
End User
-
Finance/Procurement Department
-
R&D Department
Report Objectives
-
To define, describe, and forecast the hemostats market by type, formulation, application, and region
-
To forecast the size of the hemostats market with respect to five regional segments: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
-
To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
-
To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall hemostats market
-
To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
-
To profile the key players in the hemostats market and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
-
To track and analyze competitive developments such as product launches, agreements, collaborations, partnerships, and acquisitions in the hemostats market
-
To benchmark players within the hemostats market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
HIGHEST CAGR MARKET IN 2023
US FASTEST GROWING MARKET IN THE REGION
Growth opportunities and latent adjacency in Hemostats Market